SCHEMBL8095224

SCHEMBL8095224

C[C@H](CO)NC(=O)Nc1ccc(-c2nc(N)cc(C3(SO)CC3)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 7/20 0.34
RAB9A P51151 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
MAP4K1 Q92918 1/20 0.34
GHSR Q92847 2/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
EPHX2 P34913 1/20 0.33
ROCK2 O75116 1/20 0.33
PIK3CA P42336 3/20 0.33
HDAC4 P56524 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8099890 0.90 GHSR (0.39) PIK3CDCA12CA1CA2CA9
SCHEMBL8090988 0.85 MTOR (0.44) PIK3CDALDH1A1KDM4EMEN1MAPT
SCHEMBL8097177 0.84 PIK3CD (0.39) PIK3CDRAB9ACA12CA1CA2
SCHEMBL8083982 0.82 PIK3CD (0.34) PIK3CDALDH1A1KDM4EMEN1MAPT
SCHEMBL8096884 0.82 KDM4E (0.39) PIK3CDRAB9AALDH1A1KDM4EMEN1
SCHEMBL8091937 0.81 CA12 (0.39) PIK3CDRAB9ACA12CA1CA2
SCHEMBL8089937 0.81 KIF11 (0.39) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL8091600 0.80 PIK3CA (0.40) PIK3CDPIK3CA
SCHEMBL8097581 0.80 MAPT (0.38) PIK3CDCA12CA1CA2CA9
SCHEMBL8089094 0.79 PIK3CD (0.43) PIK3CDCA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed